359 related articles for article (PubMed ID: 6254019)
21. Selection and characterization of a murine lymphoid cell line partially deficient in S-adenosylhomocysteine hydrolase.
Kamatani N; Willis EH; Carson DA
Biochim Biophys Acta; 1983 Apr; 762(2):205-14. PubMed ID: 6600937
[TBL] [Abstract][Full Text] [Related]
22. Disposition of homocysteine in rat hepatocytes and in nontransformed and malignant mouse embryo fibroblasts following exposure to inhibitors of S-adenosylhomocysteine catabolism.
Svardal AM; Djurhuus R; Refsum H; Ueland PM
Cancer Res; 1986 Oct; 46(10):5095-100. PubMed ID: 3756867
[TBL] [Abstract][Full Text] [Related]
23. Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation.
Van De Wiele CJ; Vaughn JG; Blackburn MR; Ledent CA; Jacobson M; Jiang H; Thompson LF
J Clin Invest; 2002 Aug; 110(3):395-402. PubMed ID: 12163459
[TBL] [Abstract][Full Text] [Related]
24. The effect of aliphatic adenine analogues on S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in intact rat hepatocytes.
Schanche JS; Schanche T; Ueland PM; Holý A; Votruba I
Mol Pharmacol; 1984 Nov; 26(3):553-8. PubMed ID: 6493210
[TBL] [Abstract][Full Text] [Related]
25. S-adenosylhomocysteine hydrolase activity, deoxyadenosine triphosphate accumulation, and competence of thymocyte and spleen leucocyte response to mitogens in coformycin-treated mice.
Lukey T; Snyder FF
Biochem Pharmacol; 1983 Apr; 32(8):1399-406. PubMed ID: 6860359
[TBL] [Abstract][Full Text] [Related]
26. Disposition of homocysteine and S-3-deazaadenosylhomocysteine in cells exposed to 3-deazaadenosine.
Svardal A; Djurhuus R; Ueland PM
Mol Pharmacol; 1986 Aug; 30(2):154-8. PubMed ID: 3736540
[TBL] [Abstract][Full Text] [Related]
27. Effect of 2'-deoxycoformycin infusion on S-adenosylhomocysteine hydrolase and the amount of S-adenosylhomocysteine and related compounds in tissues of mice.
Helland S; Ueland PM
Cancer Res; 1983 Sep; 43(9):4142-7. PubMed ID: 6603264
[TBL] [Abstract][Full Text] [Related]
28. S-Adenosylhomocysteine hydrolase activity in a lymphoblastoid cell line from a patient with adenosine deaminase dificiency disease.
Tsuchiya S; Nakae S; Konno T; Tada K
J Inherit Metab Dis; 1981; 4(4):197-201. PubMed ID: 6796770
[TBL] [Abstract][Full Text] [Related]
29. Effects of 4'-modified analogs of aristeromycin on the metabolism of S-adenosyl-L-homocysteine in murine L929 cells.
Ault-Riché DB; Lee Y; Yuan CS; Hasobe M; Wolfe MS; Borcherding DR; Borchardt RT
Mol Pharmacol; 1993 Jun; 43(6):989-97. PubMed ID: 8316227
[TBL] [Abstract][Full Text] [Related]
30. S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in various tissues of mice given injections of 9-beta-D-arabinofuranosyladenine.
Helland S; Ueland PM
Cancer Res; 1983 Apr; 43(4):1847-50. PubMed ID: 6831422
[TBL] [Abstract][Full Text] [Related]
31. Adenosine kinase deficiency is associated with developmental abnormalities and reduced transmethylation.
Moffatt BA; Stevens YY; Allen MS; Snider JD; Pereira LA; Todorova MI; Summers PS; Weretilnyk EA; Martin-McCaffrey L; Wagner C
Plant Physiol; 2002 Mar; 128(3):812-21. PubMed ID: 11891238
[TBL] [Abstract][Full Text] [Related]
32. Proposed explanation for S-adenosylhomocysteine hydrolase deficiency in purine nucleoside phosphorylase and hypoxanthine-guanine phosphoribosyltransferase-deficient patients.
Hershfield MS
J Clin Invest; 1981 Mar; 67(3):696-701. PubMed ID: 6782120
[TBL] [Abstract][Full Text] [Related]
33. Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.
Mitchell BS; Mejias E; Daddona PE; Kelley WN
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5011-4. PubMed ID: 311004
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
Bagnara AS; Hershfield MS
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
[TBL] [Abstract][Full Text] [Related]
35. Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.
Kubota M; Carrera CJ; Wasson DB; Carson DA
Biochim Biophys Acta; 1984 May; 804(1):37-43. PubMed ID: 6372866
[TBL] [Abstract][Full Text] [Related]
36. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.
Hershfield MS; Kredich NM; Ownby DR; Ownby H; Buckley R
J Clin Invest; 1979 Apr; 63(4):807-11. PubMed ID: 312296
[TBL] [Abstract][Full Text] [Related]
37. S-adenosyl-L-homocysteine: simplified enzymatical preparation with high yield.
Chabannes B; Gharib A; Cronenberger L; Pachéco H
Prep Biochem; 1982; 12(5):395-415. PubMed ID: 7170303
[TBL] [Abstract][Full Text] [Related]
38. Deoxyadenosine toxicity and cell cycle arrest in hydroxyurea-resistant S49 T-lymphoma cells.
Albert DA; Nodzenski E
Exp Cell Res; 1988 Dec; 179(2):417-28. PubMed ID: 3056732
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the cAMP binding site of purified S-adenosyl-homocysteine hydrolase from bovine kidney.
Kloor D; Danielyan L; Osswald H
Biochem Pharmacol; 2002 Oct; 64(8):1201-6. PubMed ID: 12234600
[TBL] [Abstract][Full Text] [Related]
40. Differential incorporation of 2'-deoxyadenosine into human peripheral lymphocytes.
Burgess FW; Stoeckler JD; Parks RE
Biochem Pharmacol; 1985 Sep; 34(18):3353-60. PubMed ID: 3929793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
